T. Rowe Price Investment Management
RVMD icon

T. Rowe Price Investment Management’s Revolution Medicines RVMD Stock Holding History

T. Rowe Price Investment Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.6M Sell
664,047
-1,536,329
-70% -$155M 0.04% 314
2025
Q4 		$175M Sell
2,200,376
-2,581,942
-54% -$169M 0.11% 178
2025
Q3 		$223M Buy
4,782,318
+93,020
+2% +$3.64M 0.14% 162
2025
Q2 		$173M Buy
4,689,298
+3,015,869
+180% +$116M 0.11% 199
2025
Q1 		$59.2M Buy
+1,673,429
New +$67.9M 0.04% 364

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management's RVMD Position: Q1 2026 in Review

T. Rowe Price Investment Management reduced its Revolution Medicines (RVMD) stake by 70% in Q1 2026, selling an estimated $155M and leaving 664,047 shares worth $64.6M. The position accounts for 0.04% of the portfolio, ranked #314.

T. Rowe Price Investment Management first reported a position in RVMD in Q1 2025 and has held it in 5 quarters since. The position peaked at $223M in Q3 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • T. Rowe Price Investment Management held 664,047 shares of Revolution Medicines worth $64.6M as of Q1 2026.
  • T. Rowe Price Investment Management sold 1,536,329 Revolution Medicines shares in Q1 2026, an estimated $155M.
  • Revolution Medicines made up 0.04% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #314 holding.
  • T. Rowe Price Investment Management first reported a position in Revolution Medicines in Q1 2025 and has held it in 5 quarters since.
  • T. Rowe Price Investment Management's Revolution Medicines position peaked at $223M in Q3 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.